Journal article
Phase II study of sorafenib (BAY 43–9006) in combination with gemcitabine in recurrent epithelial ovarian cancer: A PMH phase II consortium trial
Abstract
5084
Authors
Welch S; Hirte H; Schilder RJ; Elit L; Townsley C; Tinker L; Pond G; Afinec A; Wright JJ; Oza AM
Journal
Journal of Clinical Oncology, Vol. 24, No. 18_suppl, pp. 5084–5084
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
June 20, 2006
DOI
10.1200/jco.2006.24.18_suppl.5084
ISSN
0732-183X